Your session is about to expire
← Back to Search
IDP-118 Lotion for Psoriasis
Study Summary
This trial will test a topical treatment for plaque psoriasis to see if it is safe and effective, with the potential to suppress the body's HPA axis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 3 trial • 203 Patients • NCT02462070Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 4 and 16 years old.I am willing to use birth control during the study.I have moderate to severe psoriasis, not including my face, scalp, underarms, or skin folds.I can stay out of the sun and away from UV lights during the study.I have psoriasis covering 10% of my body, excluding my face, scalp, and certain areas.
- Group 1: IDP-118 Lotion
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there presently opportunities for individuals to participate in this study?
"Affirmative. According to clinicaltrials.gov, this medical experiment is currently enrolling participants and was first advertised on March 24th 2021. 45 volunteers are required from 6 different healthcare facilities with the most recent update being posted June 6th 2022."
Has the FDA approved IDP-118 Lotion for therapeutic use?
"As this is a Phase 4 trial and the drug has already been approved, we have judged IDP-118 Lotion to be of high safety with a score of 3."
Are there any facilities within this city that are currently conducting the clinical trial?
"This study is recruiting patients from 6 different centres located in cities like Miami, Louisville and Murray. If you choose to participate, it would be wise to select the clinical trial site closest to your residence in order to reduce travel requirements."
Are any participants over 20 years of age currently enrolled in the clinical trial?
"According to the eligibility requirements, this clinical trial is intended for participants aged 4-17. In comparison, 31 trials are open for those below 18 and 142 have been designed with patients over 65 in mind."
How many people can potentially be recruited for this research project?
"Yes, records on clinicaltrials.gov demonstrate that this trial is currently accepting patients. The research was first posted in March 2021 and has been modified as recently June 6th 2022 with the goal of recruiting 45 individuals from six distinct sites."
To whom is this scientific inquiry open?
"This clinical trial is recruiting 45 paediatric patients aged between 4 and 17 who have been clinically diagnosed with psoriasis. To be considered, they must also possess a plaque covering at least 10% body surface area (excluding face, scalp, axillae and intertriginous areas) as well as an Investigator's Global Assessment score of 3 or 4 when assessed by a doctor. Moreover, females within the age group above 9 years old must practice effective contraception for the duration of the study while all participants are expected to avoid prolonged exposure to ultraviolet radiation from natural and artificial sources throughout their involvement in this experiment."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Average response time
- < 2 Days
Most responsive sites:
- Bausch Site 3: < 48 hours
Share this study with friends
Copy Link
Messenger